1.Adherence to Uric Acid Lowering Agent of Gouty Patients.
Kyeong Min SON ; Young Il SEO ; In Je KIM ; Young Deok BAE ; Young Ok JUNG ; Myeong Jin CHA ; Hyun Ah KIM
The Journal of the Korean Rheumatism Association 2010;17(2):162-167
OBJECTIVE: Gout is crystal-induced arthritis with hyperuricemia. Uric acid lowering agent (UALA) is the maintenance drug of its treatment. Drug adherence is an important factor that influences treatment outcome. The purpose this study was to examine the drug adherence to UALA of 303 gouty patients and to analyze the factors associated with compliance. METHODS: We retrospectively assessed adherence to UALA in 303 patients who visited three hospitals affiliated with Hallym University. Patients were diagnosed as gout and used UALA with at least 6 month follow-up. Two adherence measures were calculated, the percentage of days covered (PDC) and the time until an extended break (at least 60 days) in treatment. A PDC <70% was considered poor adherence and factors associated with poor adherence were examined. RESULTS: Among the 303 patients, 283 (93.4%) were male. Mean age was 55.4+/-13.7 years. Comorbidities included hypertension in 117 (38.6%), diabetic mellitus in 108 (35.6%), angina in 107 (35.3%), myocardial infarction in 108 (35.6%), and heart failure in 113 (37.3%). The mean PDC was 65.8% with 63.4% of patients considered poorly compliant over the study period. Mean treatment duration before an extended break occurred was 203.5 days. Factors associated with good adherence included hypertension and prescription from rheumatologist. CONCLUSION: In our study, adherence to UALA in gouty patient was poor. Understanding the factors associated with adherence to UALA and proper education of gouty patients to improve drug adherence are needed.
Arthritis
;
Comorbidity
;
Compliance
;
Follow-Up Studies
;
Gout
;
Heart Failure
;
Humans
;
Hypertension
;
Hyperuricemia
;
Male
;
Myocardial Infarction
;
Prescriptions
;
Retrospective Studies
;
Treatment Outcome
;
Uric Acid
2.Immunohistochemical Localization of a Dopamine Releasing Protein in Human Brain.
Ki Young SHIN ; Sang Do BAE ; Jung Joong KIM ; Seong Man NAU ; Myeong Ok KIM ; Kyung Je CHO ; Bong Hee LEE ; Wan sung CHOI ; Hyun Joon SOHN ; Sang Ho BAIK
Korean Journal of Physical Anthropology 1994;7(2):171-186
In order to elucidate the existence and locality of DARP in the human brain, immunohistochemical identification was done in the brain tissues. This glycoprotein was distributed in paraventricular nucleus and thalamic reticular nucleus of diencephalon, substantia nigra and inferior colliculus of mesencephalon, medial vestibular nucleus, medial longitudinal nucleus, lateral reticular nucleus of medulla oblongata. And they follows a close distribution to that of catecholamine (CA) rich in either CA fiber or CA neuronal cell groups as previously reported by others using tyrosine hydroxylase (TH) as a marker. This striking similarities in the topographic arrangement of the DARP-positive reaction product and the TH-positive reaction product is another argument favoring the view that DARP is involved in the regulation of catecholaminergic neurons.
Brain*
;
Diencephalon
;
Dopamine*
;
Glycoproteins
;
Humans*
;
Inferior Colliculi
;
Medulla Oblongata
;
Mesencephalon
;
Neurons
;
Paraventricular Hypothalamic Nucleus
;
Strikes, Employee
;
Substantia Nigra
;
Tyrosine 3-Monooxygenase
;
Vestibular Nuclei
3.Analysis of Korean Carotid Intima-Media Thickness in Korean Healthy Subjects and Patients with Risk Factors: Korea Multi-Center Epidemiological Study.
Jang Ho BAE ; Ki Bae SEUNG ; Hae Ok JUNG ; Ki Young KIM ; Ki Dong YOO ; Chul Min KIM ; Seong Wook CHO ; Sang Kyoon CHO ; Young Kwon KIM ; Moo Yong RHEE ; Myeong Chan CHO ; Ki Seok KIM ; Seung Won JIN ; Jong Min LEE ; Kee Sik KIM ; Dae Woo HYUN ; Yun Kyung CHO ; In Whan SEONG ; Jin Ok JEONG ; Soon Chang PARK ; Jun Young JEONG ; Jeong Teak WOO ; Gwanpyo KOH ; Sang Wook LIM
Korean Circulation Journal 2005;35(7):513-524
BACKGROUND AND OBJECTIVES: We performed this study to evaluate the common carotid artery intima-media thickness (CCA IMT), and its correlation with several clinical variables, including the 10 year coronary heart disease (10 Yr CHD) risk in both healthy and hyperlipidemic hypertensive (HH) Koreans. SUBJECTS AND METHODS: This was a multi-centered prospective epidemiological study. The study population consisted of 227 healthy subjects without risk factors, with the exception of age (mean 49 years old, 114 males), and 243 HH subjects (mean 51 years old, 120 males). The carotid IMT and presence of plaques were semi automatically measured in both carotid arteries at a central reading facility. RESULTS: Linear regression analysis of all the subjects revealed that the independent factors of both CCA IMT were age, pulse pressure (PP) and HDL-cholesterol, and that of the right CCA IMT were sex and 10 Yr CHD risk. In healthy subjects, the independent factor of both CCA IMTs was age, and that of the right CCA IMT was body weight. In the HH subjects, age, sex, total cholesterol, HDL-cholesterol and PP were independent factors of both CCA IMTs, but 10 Yr CHD risk was an independent factor of only the right CCA IMT. Carotid plaques were seen in 17% of the healthy subjects and 35% of the HH subjects. An ROC curve analysis showed a right CCA IMT of 0.646 mm and left CCA IMT of 0.656 mm demonstrated 60% sensitivity and specificity in differentiating healthy from HH subjects. CONCLUSION: This result reliably demonstrates the Korean CCA IMT, as well as several other significant pieces of information.
Blood Pressure
;
Body Weight
;
Carotid Arteries
;
Carotid Artery, Common
;
Carotid Intima-Media Thickness*
;
Cholesterol
;
Coronary Disease
;
Epidemiologic Studies*
;
Humans
;
Korea*
;
Linear Models
;
Middle Aged
;
Prospective Studies
;
Risk Factors*
;
ROC Curve
;
Sensitivity and Specificity
4.The Reliability and Validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean Version (K-SADS-PL-K) .
Young Shin KIM ; Keun Ah CHEON ; Boong Nyun KIM ; Soon Ah CHANG ; Hee Jeong YOO ; Jae Won KIM ; Soo Churl CHO ; Dong Hyang SEO ; Myeong Ok BAE ; Yu Kyoung SO ; Joo Sun NOH ; Yun Joo KOH ; Keith MCBURNETT ; Bennett LEVENTHAL
Yonsei Medical Journal 2004;45(1):81-89
In order to develop a structured and objective diagnostic instrument, authors completed: (1) the translation and back translation of the Korean version of the Kiddie-Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version (K-SADS-PL) and (2) the examination of its validity and reliability of the K-SADS-PL-Korean version (K-SADS- PL) when used with Korean children. A total of 91 study subjects were recruited from child and adolescent psychiatry outpatient clinics. Clinical diagnoses were used as a gold standard for the examination of validity of K-SADS-PL-K. Consensual validity of threshold and sub-threshold diagnoses were good to excellent for attention-deficit/hyperactivity disorder (ADHD), fair for tic and oppositional defiant disorders, and poor to fair for anxiety and depressive disorders. Inter-rater and test-retest reliabilities were fair to excellent for ADHD and tic disorder. The significant correlations between the K-SADS-PL-K and Korean Child Behavior Checklist (K-CBCL) were found, which provided additional support for the concurrent validity of the K-SADS-PL-K. Sensitivities varied according to the diagnostic categories, but specificities remained high over all diagnoses, suggesting that the K-SADS-PL-K is a desirable confirmatory diagnostic tool. The results of this study suggest that the K-SADS-PL-K is an effective instrument for diagnosing major child psychiatric disorders, including ADHD, behavioral disorders and tic disorders in Korean children. Future studies will examine the validity and reliability of the K-SADS-PL-K in larger samples, including adolescents and community samples on a variety of child and adolescent psychiatric disorders.
Adolescent
;
Child
;
Human
;
Korea
;
Mood Disorders/*diagnosis
;
Predictive Value of Tests
;
*Psychiatric Status Rating Scales
;
Reproducibility of Results
;
Schizophrenia/*diagnosis
;
Sensitivity and Specificity
;
Support, Non-U.S. Gov't
;
Translations